Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ravenquest Biomed Inc RVVQF

Healthcare Industrials Drug Manufacturers - Specialty & Generic Cannabis
Ravenquest BioMed Inc is a Canada-based diversified cannabis company with divisions focused upon cannabis production, management services and consulting and specialized research and development. It provides integrated solutions to companies in the cannabis industry and provides growing and drying technologies, patient and genetic management systems, and security management solutions The company operates through the following segments - Consulting business and Cultivation and Sale of Medical Cannabis.


GREY:RVVQF - Post by User

Ravenquest Biomed Inc > Crash's Posts
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(18)
•••
Comment by fab4everon Jul 20, 2020 10:45am
131 Views
Post# 31290297

RE:RE:RE:RE:RE:RE:RE:RE:Crash's Posts

RE:RE:RE:RE:RE:RE:RE:RE:Crash's PostsI think it really boils down to not being able to grow. They had a $40-50m supply deal from Maricann/Wayland. Why didn't they focus on fulfilling this contract? With $2m upfront from Maricann/Wayland to put into actual growing.  No product = no sales. No sales = no cash flow. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities